Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Drug Delivery Systems × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 2 Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7 CNS 4 Thoracic 3 Head & Neck 3 Genitourinary 2 Tumor-Agnostic 1 Gynecologic 1 Breast 1

Conditions

Disease 1 Breast Neoplasms 1

Interventions

Trastuzumab 576 Paclitaxel 557 Cyclophosphamide 534 Docetaxel 476 Capecitabine 408 Letrozole 336 Carboplatin 314 Fulvestrant 308 Doxorubicin 276 Tamoxifen 238 pembrolizumab 220 Anastrozole 204 Epirubicin 202 exemestane 193 Radiotherapy 186 Bevacizumab 182 pertuzumab 177 Gemcitabine 172 Vinorelbine 161 Lapatinib 153 palbociclib 142 130-nm albumin-bound paclitaxel 138 Magnetic Resonance Spectroscopy 130 Albumin-Bound Paclitaxel 128 eribulin 122 Exercise 120 Fluorouracil 111 Taxes 105 Cisplatin 98 Everolimus 96

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01373671 2020-08-07

DBT

Siemens Medical Solutions USA - CSG

Phase NA Completed

764 enrolled 5 charts

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡